Soros Fund Management’s Idexx Laboratories IDXX Stock Holding History

Soros Fund Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,500	Closed	-$391K	–	256
2017 Q4	$391K	Buy	+2,500	New	+$394K	0.01%	172
2015 Q4	–	Sell	-6,800	Closed	-$505K	–	277
2015 Q3	$505K	Sell	6,800 -11,174	-62%	-$800K	0.01%	201
2015 Q2	$1.15M	Buy	+17,974	New	+$1.24M	0.01%	207

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Soros Fund Management's IDXX Position: Q1 2018 in Review

Soros Fund Management sold out of Idexx Laboratories (IDXX) in Q1 2018, closing a stake of 2,500 shares — an estimated $391K sold.

Soros Fund Management first reported a position in IDXX in Q2 2015 and held it in 3 quarters. The position peaked at $1.15M in Q2 2015. 645 funds tracked by Wall St. Rank hold IDXX as of Q1 2018.

Soros Fund Management reported no remaining Idexx Laboratories position as of Q1 2018 after selling out during the quarter.
Soros Fund Management sold 2,500 Idexx Laboratories shares in Q1 2018, an estimated $391K.
Soros Fund Management first reported a position in Idexx Laboratories in Q2 2015 and held it in 3 quarters.
Soros Fund Management's Idexx Laboratories position peaked at $1.15M in Q2 2015.
645 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2018.

Based on Soros Fund Management's 13F filing for Q1 2018, filed 15 May 2018.